VFEND is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Roerig. The primary component is Voriconazole.
| Product ID | 0049-3160_13fd252b-239b-423f-bba1-47b051c7b541 |
| NDC | 0049-3160 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VFEND |
| Generic Name | Voriconazole |
| Dosage Form | Powder, For Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-03-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021630 |
| Labeler Name | Roerig |
| Substance Name | VORICONAZOLE |
| Active Ingredient Strength | 40 mg/mL |
| Pharm Classes | Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2003-03-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021630 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-03-28 |
| Ingredient | Strength |
|---|---|
| VORICONAZOLE | 40 mg/mL |
| SPL SET ID: | ce3ef5cf-3087-4d92-9d94-9eb8287228db |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0049-3160 | VFEND | voriconazole |
| 0049-3170 | VFEND | voriconazole |
| 0049-3180 | VFEND | voriconazole |
| 0049-3190 | VFEND | voriconazole |
| 55154-2725 | VFEND | VFEND |
| 0049-4190 | VFEND | VFEND |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VFEND 78469910 3017665 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 2004-08-19 |
![]() VFEND 76269065 not registered Dead/Abandoned |
Pfizer Inc. 2001-06-07 |
![]() VFEND 75122046 2455588 Live/Registered |
PFIZER IRELAND PHARMACEUTICALS 1996-06-19 |